“
The Nuclear Medicine Radioisotopes global market is thoroughly researched in this report, noting important aspects like market competition, global and regional growth, market segmentation and market structure. The report author analysts have estimated the size of the global market in terms of value and volume using the latest research tools and techniques. The report also includes estimates for market share, revenue, production, consumption, gross profit margin, CAGR, and other key factors. Readers can enhance their knowledge on the trading strategies, recent developments, current and future progress of the key players in the Nuclear Medicine Radioisotopes global market.
The report includes an in-depth study of the global market segment Nuclear Medicine Radioisotopes, where segments and sub-segments are analyzed in quite detail. This research will help players focus on high growth segments and modify their business strategy, if needed. The Nuclear Medicine Radioisotopes global market is segmented based on type, application and geography. The regional segmentation research presented in the report provides players with valuable insights and data regarding key geographic markets such as North America, China, Europe, India , US, UK and MEA. Our researchers and analysts use reliable primary and secondary sources for research and data.
Major Players : Agfa-Gevaert Group
Braco
Cardiarc
Cardinal Health
CMR Naviscan (Gamma Medica Inc.)
Curium
Digirad
GE Healthcare
Nordion (Canada)
NTP Radioisotopes SOC
Positron
Segami
Siemens Healthcare
Request a sample of the report at : https://www.qyresearch.com/sample-form/form/5098117/Global-Nuclear-Medicine-Radioisotopes-Market-Report-History-and-Forecast-2017-2028-Breakdown-Data-by-Manufacturers-Key-Regions-Types-and-Application
Global Nuclear Medicine Radioisotopes Market Types: Thallium-201 (Tl-201)
Iodine (I-123)
Fluorine-18
Rubidium-82 (Rb-82)
Other
Global Nuclear Medicine Radioisotopes Market Applications: Tumor
Heart Disease
Lymphoma
Thyroid Gland
Other
Study Coverage: This section includes brief information about key products sold in the global Nuclear Medicine Radioisotopes market followed by an overview of important segments and manufacturers covered in the report. It also gives highlights of market size growth rates of different type and application segments. Furthermore, it includes information about study objectives and years considered for the complete research study.
Executive Summary: Here, the report focuses on key trends of various products and other markets. It also shares analysis of the competitive landscape, where prominent players and market concentration ratio are shed light upon. Prominent players are studied on the basis of their date of market entry, products, manufacturing base distribution, and headquarters.
Market Size by Manufacturer: In this part of the report, expansion plans, mergers and acquisitions, and price, revenue, and production by manufacturer are analyzed. This section also provides revenue and production shares by manufacturer.
Production by Region: Apart from global production and revenue shares by region, the authors have shared critical information about regional production in different geographical markets. Each regional market is analyzed taking into account vital factors, viz. import and export, key players, and revenue, besides production.
Consumption by Region: The report concentrates on global and regional consumption here. It provides figures related to global consumption by region such as consumption market share. All of the regional markets studied are assessed on the basis of consumption by country and application followed by analysis of country-level markets.
Market Size by Type: It includes analysis of price, revenue, and production by type.
Market Size by Application: It gives an overview of market size analysis by application followed by analysis of consumption market share, consumption, and breakdown data by application.
Key Industry Players: Leading players of the industry are profiled here on the basis of economic activity and plans, SWOT analysis, products, revenue, production, and other company details.
Entry Strategy for Key Countries: Entry strategies for all of the country-level markets studied in the report are provided here.
Production Forecasts: Apart from global production and revenue forecasts, this section provides production and revenue forecasts by region. It also includes forecast of key producers, where important regions and countries are taken into consideration, followed by forecast by type.
Consumption Forecast: It includes global consumption forecast by application and region. In addition, it provides consumption forecast for all regional markets studied in the report.
Opportunities and Challenges, Threats, and Affecting Factors: It includes Porter’s Five Forces analysis, market challenges, opportunities, and other market dynamics.
Key Findings of the Study: These give a clear picture of the current and future status of the global Nuclear Medicine Radioisotopes market.
Request for customization in Report: https://www.qyresearch.com/customize-request/form/5098117/Global-Nuclear-Medicine-Radioisotopes-Market-Report-History-and-Forecast-2017-2028-Breakdown-Data-by-Manufacturers-Key-Regions-Types-and-Application
Table of Contents:
1 Nuclear Medicine Radioisotopes Market Overview
1.1 Nuclear Medicine Radioisotopes Product Overview
1.2 Nuclear Medicine Radioisotopes Market Segment by Type
1.2.1 Thallium-201 (Tl-201)
1.2.2 Iodine (I-123)
1.2.3 Fluorine-18
1.2.4 Rubidium-82 (Rb-82)
1.2.5 Other
1.3 Global Nuclear Medicine Radioisotopes Market Size by Type
1.3.1 Global Nuclear Medicine Radioisotopes Market Size Overview by Type (2017-2028)
1.3.2 Global Nuclear Medicine Radioisotopes Historic Market Size Review by Type (2017-2022)
1.3.2.1 Global Nuclear Medicine Radioisotopes Sales Breakdown in Volume by Type (2017-2022)
1.3.2.2 Global Nuclear Medicine Radioisotopes Sales Breakdown in Value by Type (2017-2022)
1.3.2.3 Global Nuclear Medicine Radioisotopes Average Selling Price (ASP) by Type (2017-2022)
1.3.3 Global Nuclear Medicine Radioisotopes Forecasted Market Size by Type (2023-2028)
1.3.3.1 Global Nuclear Medicine Radioisotopes Sales Breakdown in Volume by Type (2023-2028)
1.3.3.2 Global Nuclear Medicine Radioisotopes Sales Breakdown in Value by Type (2023-2028)
1.3.3.3 Global Nuclear Medicine Radioisotopes Average Selling Price (ASP) by Type (2023-2028)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Nuclear Medicine Radioisotopes Sales Breakdown by Type (2017-2022)
1.4.2 Europe Nuclear Medicine Radioisotopes Sales Breakdown by Type (2017-2022)
1.4.3 Asia-Pacific Nuclear Medicine Radioisotopes Sales Breakdown by Type (2017-2022)
1.4.4 Latin America Nuclear Medicine Radioisotopes Sales Breakdown by Type (2017-2022)
1.4.5 Middle East and Africa Nuclear Medicine Radioisotopes Sales Breakdown by Type (2017-2022)
2 Global Nuclear Medicine Radioisotopes Market Competition by Company
2.1 Global Top Players by Nuclear Medicine Radioisotopes Sales (2017-2022)
2.2 Global Top Players by Nuclear Medicine Radioisotopes Revenue (2017-2022)
2.3 Global Top Players Nuclear Medicine Radioisotopes Price (2017-2022)
2.4 Global Top Manufacturers Nuclear Medicine Radioisotopes Manufacturing Base Distribution, Sales Area, Product Type
2.5 Nuclear Medicine Radioisotopes Market Competitive Situation and Trends
2.5.1 Nuclear Medicine Radioisotopes Market Concentration Rate (2017-2022)
2.5.2 Global 5 and 10 Largest Manufacturers by Nuclear Medicine Radioisotopes Sales and Revenue in 2021
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Medicine Radioisotopes as of 2021)
2.7 Date of Key Manufacturers Enter into Nuclear Medicine Radioisotopes Market
2.8 Key Manufacturers Nuclear Medicine Radioisotopes Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Nuclear Medicine Radioisotopes Status and Outlook by Region
3.1 Global Nuclear Medicine Radioisotopes Market Size and CAGR by Region: 2017 VS 2021 VS 2028
3.2 Global Nuclear Medicine Radioisotopes Historic Market Size by Region
3.2.1 Global Nuclear Medicine Radioisotopes Sales in Volume by Region (2017-2022)
3.2.2 Global Nuclear Medicine Radioisotopes Sales in Value by Region (2017-2022)
3.2.3 Global Nuclear Medicine Radioisotopes Sales (Volume & Value) Price and Gross Margin (2017-2022)
3.3 Global Nuclear Medicine Radioisotopes Forecasted Market Size by Region
3.3.1 Global Nuclear Medicine Radioisotopes Sales in Volume by Region (2023-2028)
3.3.2 Global Nuclear Medicine Radioisotopes Sales in Value by Region (2023-2028)
3.3.3 Global Nuclear Medicine Radioisotopes Sales (Volume & Value), Price and Gross Margin (2023-2028)
4 Global Nuclear Medicine Radioisotopes by Application
4.1 Nuclear Medicine Radioisotopes Market Segment by Application
4.1.1 Tumor
4.1.2 Heart Disease
4.1.3 Lymphoma
4.1.4 Thyroid Gland
4.1.5 Other
4.2 Global Nuclear Medicine Radioisotopes Market Size by Application
4.2.1 Global Nuclear Medicine Radioisotopes Market Size Overview by Application (2017-2028)
4.2.2 Global Nuclear Medicine Radioisotopes Historic Market Size Review by Application (2017-2022)
4.2.2.1 Global Nuclear Medicine Radioisotopes Sales Breakdown in Volume, by Application (2017-2022)
4.2.2.2 Global Nuclear Medicine Radioisotopes Sales Breakdown in Value, by Application (2017-2022)
4.2.2.3 Global Nuclear Medicine Radioisotopes Average Selling Price (ASP) by Application (2017-2022)
4.2.3 Global Nuclear Medicine Radioisotopes Forecasted Market Size by Application (2023-2028)
4.2.3.1 Global Nuclear Medicine Radioisotopes Sales Breakdown in Volume, by Application (2023-2028)
4.2.3.2 Global Nuclear Medicine Radioisotopes Sales Breakdown in Value, by Application (2023-2028)
4.2.3.3 Global Nuclear Medicine Radioisotopes Average Selling Price (ASP) by Application (2023-2028)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Nuclear Medicine Radioisotopes Sales Breakdown by Application (2017-2022)
4.3.2 Europe Nuclear Medicine Radioisotopes Sales Breakdown by Application (2017-2022)
4.3.3 Asia-Pacific Nuclear Medicine Radioisotopes Sales Breakdown by Application (2017-2022)
4.3.4 Latin America Nuclear Medicine Radioisotopes Sales Breakdown by Application (2017-2022)
4.3.5 Middle East and Africa Nuclear Medicine Radioisotopes Sales Breakdown by Application (2017-2022)
5 North America Nuclear Medicine Radioisotopes by Country
5.1 North America Nuclear Medicine Radioisotopes Historic Market Size by Country
5.1.1 North America Nuclear Medicine Radioisotopes Sales in Volume by Country (2017-2022)
5.1.2 North America Nuclear Medicine Radioisotopes Sales in Value by Country (2017-2022)
5.2 North America Nuclear Medicine Radioisotopes Forecasted Market Size by Country
5.2.1 North America Nuclear Medicine Radioisotopes Sales in Volume by Country (2023-2028)
5.2.2 North America Nuclear Medicine Radioisotopes Sales in Value by Country (2023-2028)
6 Europe Nuclear Medicine Radioisotopes by Country
6.1 Europe Nuclear Medicine Radioisotopes Historic Market Size by Country
6.1.1 Europe Nuclear Medicine Radioisotopes Sales in Volume by Country (2017-2022)
6.1.2 Europe Nuclear Medicine Radioisotopes Sales in Value by Country (2017-2022)
6.2 Europe Nuclear Medicine Radioisotopes Forecasted Market Size by Country
6.2.1 Europe Nuclear Medicine Radioisotopes Sales in Volume by Country (2023-2028)
6.2.2 Europe Nuclear Medicine Radioisotopes Sales in Value by Country (2023-2028)
7 Asia-Pacific Nuclear Medicine Radioisotopes by Region
7.1 Asia-Pacific Nuclear Medicine Radioisotopes Historic Market Size by Region
7.1.1 Asia-Pacific Nuclear Medicine Radioisotopes Sales in Volume by Region (2017-2022)
7.1.2 Asia-Pacific Nuclear Medicine Radioisotopes Sales in Value by Region (2017-2022)
7.2 Asia-Pacific Nuclear Medicine Radioisotopes Forecasted Market Size by Region
7.2.1 Asia-Pacific Nuclear Medicine Radioisotopes Sales in Volume by Region (2023-2028)
7.2.2 Asia-Pacific Nuclear Medicine Radioisotopes Sales in Value by Region (2023-2028)
8 Latin America Nuclear Medicine Radioisotopes by Country
8.1 Latin America Nuclear Medicine Radioisotopes Historic Market Size by Country
8.1.1 Latin America Nuclear Medicine Radioisotopes Sales in Volume by Country (2017-2022)
8.1.2 Latin America Nuclear Medicine Radioisotopes Sales in Value by Country (2017-2022)
8.2 Latin America Nuclear Medicine Radioisotopes Forecasted Market Size by Country
8.2.1 Latin America Nuclear Medicine Radioisotopes Sales in Volume by Country (2023-2028)
8.2.2 Latin America Nuclear Medicine Radioisotopes Sales in Value by Country (2023-2028)
9 Middle East and Africa Nuclear Medicine Radioisotopes by Country
9.1 Middle East and Africa Nuclear Medicine Radioisotopes Historic Market Size by Country
9.1.1 Middle East and Africa Nuclear Medicine Radioisotopes Sales in Volume by Country (2017-2022)
9.1.2 Middle East and Africa Nuclear Medicine Radioisotopes Sales in Value by Country (2017-2022)
9.2 Middle East and Africa Nuclear Medicine Radioisotopes Forecasted Market Size by Country
9.2.1 Middle East and Africa Nuclear Medicine Radioisotopes Sales in Volume by Country (2023-2028)
9.2.2 Middle East and Africa Nuclear Medicine Radioisotopes Sales in Value by Country (2023-2028)
10 Company Profiles and Key Figures in Nuclear Medicine Radioisotopes Business
10.1 Agfa-Gevaert Group
10.1.1 Agfa-Gevaert Group Corporation Information
10.1.2 Agfa-Gevaert Group Introduction and Business Overview
10.1.3 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
10.1.4 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Products Offered
10.1.5 Agfa-Gevaert Group Recent Development
10.2 Braco
10.2.1 Braco Corporation Information
10.2.2 Braco Introduction and Business Overview
10.2.3 Braco Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
10.2.4 Braco Nuclear Medicine Radioisotopes Products Offered
10.2.5 Braco Recent Development
10.3 Cardiarc
10.3.1 Cardiarc Corporation Information
10.3.2 Cardiarc Introduction and Business Overview
10.3.3 Cardiarc Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
10.3.4 Cardiarc Nuclear Medicine Radioisotopes Products Offered
10.3.5 Cardiarc Recent Development
10.4 Cardinal Health
10.4.1 Cardinal Health Corporation Information
10.4.2 Cardinal Health Introduction and Business Overview
10.4.3 Cardinal Health Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
10.4.4 Cardinal Health Nuclear Medicine Radioisotopes Products Offered
10.4.5 Cardinal Health Recent Development
10.5 CMR Naviscan (Gamma Medica Inc.)
10.5.1 CMR Naviscan (Gamma Medica Inc.) Corporation Information
10.5.2 CMR Naviscan (Gamma Medica Inc.) Introduction and Business Overview
10.5.3 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
10.5.4 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Products Offered
10.5.5 CMR Naviscan (Gamma Medica Inc.) Recent Development
10.6 Curium
10.6.1 Curium Corporation Information
10.6.2 Curium Introduction and Business Overview
10.6.3 Curium Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
10.6.4 Curium Nuclear Medicine Radioisotopes Products Offered
10.6.5 Curium Recent Development
10.7 Digirad
10.7.1 Digirad Corporation Information
10.7.2 Digirad Introduction and Business Overview
10.7.3 Digirad Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
10.7.4 Digirad Nuclear Medicine Radioisotopes Products Offered
10.7.5 Digirad Recent Development
10.8 GE Healthcare
10.8.1 GE Healthcare Corporation Information
10.8.2 GE Healthcare Introduction and Business Overview
10.8.3 GE Healthcare Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
10.8.4 GE Healthcare Nuclear Medicine Radioisotopes Products Offered
10.8.5 GE Healthcare Recent Development
10.9 Nordion (Canada)
10.9.1 Nordion (Canada) Corporation Information
10.9.2 Nordion (Canada) Introduction and Business Overview
10.9.3 Nordion (Canada) Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
10.9.4 Nordion (Canada) Nuclear Medicine Radioisotopes Products Offered
10.9.5 Nordion (Canada) Recent Development
10.10 NTP Radioisotopes SOC
10.10.1 NTP Radioisotopes SOC Corporation Information
10.10.2 NTP Radioisotopes SOC Introduction and Business Overview
10.10.3 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
10.10.4 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Products Offered
10.10.5 NTP Radioisotopes SOC Recent Development
10.11 Positron
10.11.1 Positron Corporation Information
10.11.2 Positron Introduction and Business Overview
10.11.3 Positron Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
10.11.4 Positron Nuclear Medicine Radioisotopes Products Offered
10.11.5 Positron Recent Development
10.12 Segami
10.12.1 Segami Corporation Information
10.12.2 Segami Introduction and Business Overview
10.12.3 Segami Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
10.12.4 Segami Nuclear Medicine Radioisotopes Products Offered
10.12.5 Segami Recent Development
10.13 Siemens Healthcare
10.13.1 Siemens Healthcare Corporation Information
10.13.2 Siemens Healthcare Introduction and Business Overview
10.13.3 Siemens Healthcare Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2017-2022)
10.13.4 Siemens Healthcare Nuclear Medicine Radioisotopes Products Offered
10.13.5 Siemens Healthcare Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Nuclear Medicine Radioisotopes Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Nuclear Medicine Radioisotopes Industrial Chain Analysis
11.4 Nuclear Medicine Radioisotopes Market Dynamics
11.4.1 Nuclear Medicine Radioisotopes Industry Trends
11.4.2 Nuclear Medicine Radioisotopes Market Drivers
11.4.3 Nuclear Medicine Radioisotopes Market Challenges
11.4.4 Nuclear Medicine Radioisotopes Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Nuclear Medicine Radioisotopes Distributors
12.3 Nuclear Medicine Radioisotopes Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
About Us:
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.
Contact US:
QY RESEARCH, INC.
17890 CASTLETON STREET
SUITE 369, CITY OF INDUSTRY
CA – 91748, UNITED STATES OF AMERICA
+1 626 539 9760 / +91 8669986909